補體因子P(CFP)多克隆抗體
Polyclonal Antibody to Complement Factor P (CFP)
CF-P; PFC; Properdin
- 編號PAA783Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA783Hu02-補體因子P(CFP)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種Sus scrofa; Porcine (Pig，豬)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 623 ¥ 1453 ¥ 2076 ¥ 5190 ¥ 20760
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Spleen Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human CFP Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant CFP, Human.
-
Western Blot; Sample: Human Serum;
Primary Ab: 1μg/ml Rabbit Anti-Human CFP Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對CFP的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CFP。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA783Hu01 | 補體因子P(CFP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA783Hu02 | 補體因子P(CFP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA783Hu01 | 補體因子P(CFP)多克隆抗體 | WB; IHC; ICC; IP; FCM |
| PAA783Hu02 | 補體因子P(CFP)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA783Hu71 | 補體因子P(CFP)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA783Hu22 | 補體因子P(CFP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA783Hu | 補體因子P(CFP)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA783Hu | 補體因子P(CFP)檢測試劑盒(化學發光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA783Hu | 補體因子P(CFP)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| BMC Nephrology | Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis [BioMed: 14712369] |
| Lupus | Complement alternative pathway activation associated with pulmonary hypertension in lupus nephritis patients [Pubmed: 31296141] |
| CLINICAL AND EXPERIMENTAL IMMUNOLOGY | The alternative complement pathway in ANCA‐associated vasculitis: further evidence and a meta‐analysis [Pubmed: 32691878] |
| Am J Med Sci | Lupus Nephritis with Obvious IgA deposits in the Kidneys [34332968] |
留言咨詢
